Phase 1 Connective Tissue Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

ANCA Associated Vasculitis (AAV)SLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more

Institute of Hematology & Blood Diseases Hospital, China12 enrolled1 locationNCT07315087

Recruiting

Phase 1Phase 2

ADSCs Therapy in Patients With CTD-ILD

Interstitial Lung DiseaseConnective Tissue Diseases

China Medical University Hospital16 enrolled1 locationNCT06574581